Skip to content
by Legal Desire
SIGN IN GO PRO
2 September 2022

Herbert Smith Freehills Advises Sponsors On Biocytogen Pharmaceuticals’ Hong Kong Ipo

Capital Markets & IPO Healthcare & Life Sciences Completed Hong Kong

Advising firms

Herbert Smith Freehills Kramer
Underwriters acting for Goldman Sachs and China International Capital Corporation

Deal team

17 lawyers named
LawyerFirmSeniorityPracticeOffice
Matt Emsley Lead Herbert Smith Freehills Kramer Partner Not stated Hong Kong
Stanley Xie Lead Herbert Smith Freehills Kramer Partner Not stated Not stated
Jin Kong Lead Herbert Smith Freehills Kramer Other Not stated Hong Kong
Jaime Fong Herbert Smith Freehills Kramer Senior associate Not stated Not stated
Cyrus Wong Herbert Smith Freehills Kramer Associate Not stated Not stated
Kristina Li Herbert Smith Freehills Kramer Associate Not stated Not stated
Sean Ji Herbert Smith Freehills Kramer Associate Not stated Not stated
Haiyun Chen Herbert Smith Freehills Kramer Associate Not stated Not stated
Ting Wang Herbert Smith Freehills Kramer Associate Not stated Not stated
Han Ye Herbert Smith Freehills Kramer Other Not stated Not stated
Ariel Lin Herbert Smith Freehills Kramer Other Not stated Not stated
Hilary Chong Herbert Smith Freehills Kramer Other Not stated Not stated
Colbert Hung Herbert Smith Freehills Kramer Trainee Not stated Not stated
Jessica Lu Herbert Smith Freehills Kramer Other Not stated Not stated
Tiffany Chan Herbert Smith Freehills Kramer Other Not stated Not stated
Marine Jin Herbert Smith Freehills Kramer Other Not stated Not stated
Jean Zhou Herbert Smith Freehills Kramer Other Not stated Not stated

14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
Not stated
Counterparties
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Issuer)
Goldman Sachs (Underwriters)
China International Capital Corporation (Underwriters)